NCT07455786 Modified Trabeculectomy After Failure of Combined Phaco With GATT
| NCT ID | NCT07455786 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assiut University |
| Condition | Glaucoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-04-01 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
These procedures include deep non-penetrating sclerectomy, viscocanalostomy, and small incision trabeculectomy, avoiding Tenon's capsule.
Eligibility Criteria
Inclusion Criteria: * All patients had combined phaco surgery with GATT. * All patients had phaco with goinopuncture. Exclusion Criteria: * Healthy patient. * No history of phaco surgery with GATT or goinopuncture.
Frequently Asked Questions
Who can join the NCT07455786 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 70 Years, studying Glaucoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07455786 currently recruiting?
Yes, NCT07455786 is actively recruiting participants. Visit ClinicalTrials.gov or contact Assiut University to inquire about joining.
Where is the NCT07455786 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT07455786 clinical trial?
NCT07455786 is sponsored by Assiut University. The trial plans to enroll 20 participants.